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Sleeve gastrectomyAbstract Noninvasive continuous positive airway pressure ventilation may improve postoperative
oxygenation, lung functions and reduce postoperative complications in morbidly obese patients
undergoing sleeve gastrectomy.
Aim: Evaluation of the effect of immediate postoperative CPAP therapy after sleeve gastrectomy
in improving oxygenation, pulmonary functions values, reducing atelectasis and reducing postoper-
ative pulmonary complications.
Patients and methods: Single blind randomized clinical trial, was conducted in Gastroenterology
Centre and Chest Department, Mansoura University Hospitals during the period from 2013 to 2015
on 46 morbidly obese patients after sleeve gastrectomy. Patients were divided into two groups;
group (A) immediately placed on CPAP (8–12 cm H2O) for at least 8 h and group (B) control
group, received oxygen support 4–6 L per minute via nasal catheter. The primary end points of
the study were CXR, spirometric pulmonary function (FEV1, FVC, FEV1/FVC) and O2 tension
and saturation measured 24 h postoperatively and the secondary endpoints were postoperative
pulmonary complications during the first 2 weeks.
Results: As regards FEV1 and FVC, there was a high statistically significant difference between
both groups after treatment and there was a statistically significant increase in group (A) after treat-
ment versus before treatment. As regards oxygen tension and saturation there were high statistically
significant differences between both groups after treatment. There was a statistically significant
decrease in atelectasis in group (A). There were statistically significant differences between both
groups as regards postoperative respiratory failure and persistent atelectasis but there were no
statistically significant differences in pneumonia and gastric distension.
Conclusion: The use of immediate CPAP after sleeve gastrectomy in morbidly obese patients is
effective in improving oxygenation, spirometric values, reducing atelectasis and decreasing postop-
erative pulmonary complications.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Morbidly obese patients are at an increased risk for postoper-
ative pulmonary complications such as atelectasis due to loss
of functional residual capacity, anesthesia, and surgery, and
upper airway obstruction due to obstructive sleep apnea syn-
drome (OSA), anesthesia, and opioid analgesia [1].
Obstructive sleep apnea may be present in up to 80% of
bariatric patients. The presence of OSA can increase the occur-
rence of postoperative pulmonary complications [2]. Noninva-
sive ventilation devices such as continuous positive airway
pressure (CPAP) and bi-level positive airway pressure (BiPAP)
can be used to reduce the incidence of postoperative pul-
monary complications in obese patients undergoing bariatric
surgery [3].
The immediate period after tracheal extubation is a
hazardous period because of the risks of airway obstruction,
narcosis, residual anesthesia, and residual neuromuscular
blockade [4]. The maintenance of positive airway pressure
immediately post extubation may result in a significant
improvement in spirometric lung functions [5].
The aim of our study was to evaluate the effect of immediate
postoperative CPAP therapy after sleeve gastrectomy in
improving oxygenation, pulmonary function values, reducing
atelectasis and reducing postoperative pulmonary
complications.Study design
Single blind randomized clinical trial in which morbidly obese
patients decided to do sleeve gastrectomy were divided into
two groups, the first group (CPAP group) were extubated
and immediately placed on CPAP (8–12 cm H2O) for at least
8 h on the first postoperative day and the second group
(oxygen group) received oxygen support after the extubation,
with a flow of 4–6 L per minute via a nasal catheter. The
primary end points of the study were chest X-ray, spirometric
pulmonary function tests (FEV1, FVC, and FEV1/FVC) and
O2 tension and O2 saturation measured 24 h postoperatively
and the secondary endpoints were postoperative pulmonary
complications during the first 2 weeks. The patients were ran-
domly selected using the closed envelop method.Patients and methods
This study was conducted in Gastroenterology Centre and
Chest Department, Mansoura University Hospitals during
the period from 2013 April to 2015 October on 46 morbidly
obese patients who decided to do sleeve gastrectomy, with
the following inclusion criteria: BMI > 40, age 18–65 years,
presence of obesity for at least 3 years without hormonal prob-
lems, failure to lose weight for at least 1 year despite drug and
dietary therapies, can understand the operation and postoper-
ative requirements and complications. Patients with chronic or
acute pulmonary disease were not included, and neither who
needed invasive mechanical ventilation at the end of the
surgery.
Patients were randomly divided into two groups, group A
(CPAP group); patients were extubated and immediately
placed on CPAP via a portable CPAP (S9, RESMED)8–12 cm H2O for at least 8 h on the first postoperative day
with a full facemask. Group B (oxygen group); patients
received oxygen support after the extubation, with a flow of
4–6 L per minute via a nasal catheter as advised in the hospital
protocol. Local ethical approval had been obtained. Patients
signed their written consents after detailed explanation of the
study protocol.
All included patients were subjected to the following:
One day before operation
Complete medical history and clinical examination.
Routine investigations were done (CBC, liver function tests,
random blood glucose, serum creatinine and coagulation
profile).
Thyroid profile and serum cortisol.
ECG, chest X-ray and echocardiography.
Spirometric pulmonary function tests (FEV1, FVC and
FEV1/FVC were done preoperatively and 24 h postopera-
tively), three spirometric attempts were measured, and the best
value was recorded preoperatively and 24 h postoperatively via
portable spirometry (MIR. spirolabII, Italy).
Body mass index (BMI) and ideal body weight (IBW) were
calculated and enlisted in the patient’s file as follow:
BMI ¼ body weightðin kgÞ=height2ðin metersÞ
IBW ¼ for men ¼ 50þ 0:91fðheight in cm-152:4Þg
For women ¼ 45:5þ 0:91fðheight in cm-152:4ÞgIn the morning of the operation at recovery room
After an overnight fasting, the patients were transferred to the
operating room and 20-gauge IV cannula was placed. Midazo-
lam 0.03 mg/kg was given I.V to alleviate anxiety. Patients
placed in semi sitting position, monitored for ECG, blood
pressure and oxygen saturation.
Induction of anesthesia
After five minutes of preoxygenation all patients were induced
with fentanyl 1–1.5 lg/kg and propofol 1.5–2 mg/kg (TBW) till
loss of verbal contact with patients. Endotracheal intubation
was facilitated by succinylcholine 1–1.5 mg/kg (TBW), posi-
tion of the tube was confirmed by capnography and ausculta-
tion. All patients were mechanically ventilated through closed
circuit with FGF around 2 L/m, using ventilator (GE Datex-
Ohmeda Aisys (USA) ventilator) with initial settings (tidal
volume 6–8 ml/kg of ideal body weight, respiratory rate
12–16 BPM, I:E 1:2, PEEP 5–7 cm H2O, FiO2 0.4). Ventilatory
parameters were modified to maintain Et CO2 between 30 and
35 mmHg. Before starting surgery radial artery catheter,
nasogastric tube, and silicon Foley catheter were inserted.
Intra operative monitoring was achieved by 5 lead ECG, pulse
oximetry and blood pressure.
Recovery and extubation
After termination of the surgery, discontinuation of the anes-
thesia and reversal of muscle relaxant was prepared and given
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neostigmine (0.06 mg/kg). Extubation was done after fulfill-
ment of the extubation criteria (e.g.: eye opening, following
commands, sustained head lift, full recovery from muscle
relaxation: spontaneous breathing with good tidal volume
and normocapnia).
Postoperative care unit
In postoperative care unit all patients were nursed in semisit-
ting or sitting position. All patients were followed up by basic
vital signs, oxygen supplementation through nasal canula was
given in all patients however CPAP device was placed to group
(A) only immediately post extubation. NSAIDs were preferred
for postoperative analgesia in the form of ketorolac (30 mg) if
not sufficient morphine 0.1–0.2 mg /kg of adjusted body
weight was given. All patients remain for at least two hours
in the postoperative care unit then are transferred to the ward
after fulfillment of discharge criteria using modified Aldert’s
score [6] equal or more than 9.
Statistical analysis
Data were analyzed using SPSS (Statistical Package for Social
Sciences) version 15. Qualitative data were presented as num-
ber and percent. Comparison between groups was done by
Chi-Square test. Quantitative data were presented as mean
± SD. Paired t-test was used for comparison within groups.
Student’s t-test was used to compare between two groups.
Non parametric data were presented as min–max and median.
Mann–Whitney test was used for comparison between groups.
The Wilcoxon signed ranks test was used for comparison
within group. P 6 0.05 was considered to be statistically
significant.Table 1 Demographic data and anthropometric measurement of th
Group A CPAP group (n= 24)
Age 31.25 ± 10.36
Sex
Male 7 (29.2%)
Female 17 (70.8%)
BMI 58.89 ± 9.46
Neck circumference 41.17 ± 2.32
Significant P 6 0.05.
Table 2 Pulmonary function tests of the included patients preopera
Group A CPAP group (n= 24)
FEV1 before 83.50 ± 18.28
FEV1 after 93.50 ± 15.07
P (before vs. after) 0.005*
FVC before 83.08 ± 17.80
FVC after 93.29 ± 15.69
P (before vs. after) 0.004*
* Significant P 6 0.05.Results
Group A: Included 24 patients (7 males and 17 females) with a
mean age of 31.25 ± 10.36; these patients were extubated and
immediately placed on CPAP via a portable CPAP (S9,
RESMED) 8–12 cm H2O for at least 8 h on the first postoper-
ative day with a full facemask.
Group B: Included 22 patients (10 males and 12 females)
with a mean age of 26.86 ± 5.90; these patients received oxy-
gen support after extubation, with a flow of 4–6 L per minute
via a nasal catheter as a control group.
There were no statistically significant differences between
both groups as regards body mass index and neck circumfer-
ence before treatment as shown in Table 1.
Table 2 showed that there were no statistically significant
differences between both groups as regards FEV1 and FVC
preoperatively. As regards FEV1 there was a high statistically
significant increase in group (A) than group (B) after 24 h post-
operatively (P< 0.001), and there was a statistically signifi-
cant increase in group (A) after 24 h postoperatively versus
preoperatively (P= 0.005). As regards FVC there was a high
statistically significant increase in group (A) than group (B)
after 24 h postoperatively (P< 0.001), and there was a statis-
tically significant increase in group (A) after 24 h postopera-
tively versus preoperatively (P= 0.004).
Table 3 showed that there were no statistically significant
differences between both groups as regards oxygen tension
or saturation preoperatively. As regard oxygen saturation
there was a statistically significant increase in group (A) than
group (B) after 24 h postoperatively (P< 0.001), and there
was a statistically significant increase in both groups (A) and
(B) after 24 h postoperatively versus preoperatively
(P< 0.001, P= 0.012 respectively). As regards oxygen ten-
sion there was a statistically significant increase in group (A)e included patients.
Group B oxygen group (n= 22) t P
26.86 ± 5.90 1.783 0.083
12 (54.5%) 3.049 0.081
10 (45.5%)
55.89 ± 8.09 1.151 0.256
40.00 ± 2.27 1.724 0.092
tively and after 24 h postoperatively.
Group B oxygen group (n= 22) t P
75.32 ± 8.60 1.968 0.057
72.41 ± 8.82 5.722 <0.001*
0.243
73.64 ± 14.89 1.943 0.058
64.55 ± 13.16 6.697 <0.001*
0.054
Table 3 Arterial blood gases of the included patients preoperatively and after 24 h postoperatively.
Group A CPAP group (n= 24) Group B oxygen group (n= 22) t P
SaO2 before 90.83 ± 2.18 90.23 ± 2.25 0.928 0.358
SaO2 after 93.25 ± 2.15 91.14 ± 1.70 3.675 <0.001
*
P (before vs. after) <0.001* 0.012*
PaO2 before 62.29 ± 5.42 61.05 ± 3.37 0.945 0.351
PaO2 after 78.83 ± 8.31 63.27 ± 6.33 7.094 <0.001
*
P (before vs. after) <0.001* 0.049*
* Significant P 6 0.05.
Table 4 Atelectasis in chest X-ray of the included patients preoperatively and after 24 h postoperatively.
Group A CPAP group (n= 24) Group B oxygen group (n= 22) v2 P value
No % No %
Atelectasis before 16 66.7 13 59.1 0.283 0.410
Atelectasis after 6 25.0 11 50.0 3.079 0.073
P (before vs. after) 0.002* 0.414
* Significant P 6 0.05.
Table 5 Postoperative complications of the included patients after 2 weeks.
Group A CPAP group (n= 24) Group B oxygen group (n= 22) v2 P value
No % No %
Pneumonia 1 4.2 2 9.1 9.1% 0.457
Respiratory failure 0 0 4 18.2 4.779 0.029*
Persistent atelectasis 2 8.3 7 31.8 4.023 0.045*
Gastric distension 2 8.3 2 9.1 0.008 0.927
* Significant P 6 0.05.
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there was a statistically significant increase in both groups
(A) and (B) after 24 h postoperatively versus preoperatively
(P< 0.001, P= 0.049 respectively). The changes in values
were few but statistically significant due to low values of stan-
dard deviation.
Table 4 showed that there were no statistically significant
differences between both groups as regards atelectasis preoper-
atively. In group (A) there was a statistically significant
decrease in the number of patients who had atelectasis after
24 h postoperatively versus preoperatively (P= 0.002).
Table 5 showed that as regards postoperative complications
pneumonia developed in one patient in group (A) and 2
patients in group (B) and improved with antibiotic treatment.
Respiratory failure developed in 4 patients of group (B) and
one patient only needed invasive mechanical ventilation and
weaned successfully and there was a statistically significant dif-
ference between group (A) and group (B). Persistent atelectasis
was present in 2 patients of group (A) and 7 patients of group
(B) and there was a statistically significant difference between
group (A) and group (B). Gastric distension was present in 2
patients of group (A) and (B) and there was no statistically sig-
nificant difference between group (A) and (B). There was no
procedure related mortality.Discussion
Morbid obesity causes hazards to lung functions due to its
effects on mechanical ventilation, airway resistance, lung vol-
umes and respiratory muscles [7]. Also morbid obesity is asso-
ciated with dramatically increased chest wall elastance, so that,
these patients have more chance to develop atelectasis than
patients who are non-obese, so noninvasive positive pressure
ventilation (NIPPV) is widely recommended to reduce the risk
of postoperative complications [8].
The aim of our study was to evaluate the effect of immediate
postoperative CPAP therapy after sleeve gastrectomy in
improving oxygenation, pulmonary functions values, reducing
atelectasis and reducing postoperative pulmonary complications.
As regards FEV1 and FVC there was a high statistically sig-
nificant increase in group (A) than group (B) after 24 h postop-
eratively, and there was a statistically significant increase in
group (A) after 24 h postoperatively versus preoperatively.
These results were similar to Ebeo et al. [9] who evaluated
the effect of BiPAP on pulmonary functions in obese patients
after open gastric bypass surgery. Twenty-seven patients were
included: 14 received BiPAP and 13 received conventional
postoperative care. FVC and FEV1 were significantly higher
on each of the 3 consecutive postoperative days in the patients
CPAP therapy after sleeve gastrectomy 705who received BiPAP therapy. And also near to Joris et al. [10]
who used BiPAP during 12–24 h, in periods from 3 to 4 h.
They observed an increase in the FVC and FEV1 from 24%
to 30% in the group that used NIV in comparison to the con-
trol group during the measurement of the pulmonary function
in the postoperative period. Our results were similar to these
studies as we targeted similar patient group and managed them
by CPAP therapy in postoperative period which gave us near
similar results to BiPAP therapy to their patients.
In our study, both oxygen saturation and tension were
statistically significantly higher in group (A) versus group (B)
after 24 h postoperatively (P< 0.001, P< 0.001 respectively),
also there was a statistically significantly higher oxygen satura-
tion in both groups (A) and (B) after 24 h postoperatively
versus preoperatively (P< 0.001, P= 0.012 respectively).
Oxygen tension also was statistically significantly higher in
both groups (A) and (B) after 24 h postoperatively versus pre-
operatively (P< 0.001, P= 0.049 respectively). This can be
explained by the use of CPAP that restores the functional
residual capacity (FRC) to preoperative levels, improving
postoperative oxygenation [11]. Our results were in accordance
to Chalhoub et al. [12] who studied non invasive ventilation
(NIV) in morbidly obese patients undergoing open bariatric
surgery and they found that patients who used NIV demon-
strated an increase in PaO2 and SaO2 during the postoperative
period than those who did not use NIV. This indicates better
oxygenation levels with the use of NIV.
As regards atelectasis, in group (A) there was a statistically
significant decrease in atelectasis after 24 h postoperatively
versus preoperatively (P= 0.002) but in group (B) there was
no statistically significant decrease, so CPAP treatment signif-
icantly decreases atelectasis postoperatively and this is a good
effect of CPAP as we know that atelectasis actually worsens in
patients who are morbidly obese over the first 24 postoperative
hours. Loss of FRC, lung derecruitment, airway closure, and
airway obstruction predispose patients to hypoxemia [5]. High
inspired concentrations of oxygen increase the extent of
absorption atelectasis and reduce FRC further [13]. These
competing problems can be offset by the application of CPAP
during oxygen administration [14], and postoperatively [15].
Our results were comparable to Ahmad et al., who found that
the NIV has been successfully used to correct atelectasis in the
postoperative period and thus restores the FRC, prevents the
collapse of upper airways and increases the lung compliance
[16].
Postoperative complications were lower in group (A) than
group (B) as regards pneumonia but statistically insignificant,
there were statistically significant differences between both
groups as regards respiratory failure and persistent atelectasis,
and there was no difference between both groups as regards
gastric distension and there was no procedure related mortal-
ity. Our results were lower than those reported by Squadrone
et al. who studied 209 patients who were hypoxemic after
major abdominal surgery and randomized them to receive
CPAP or standard oxygen therapy. CPAP was associated with
a significant reduction in infectious complications and reintu-
bation, and a shorter duration of intensive care unit stay as
they studied larger number of patients with more comorbidi-
ties and more major abdominal surgery [17]. Substantial
aerophagia leading to pouch distension does not occur rou-
tinely during postoperative use of CPAP in patients afterlaparoscopic bariatric surgery [18] and this was similar to
our results regarding gastric distension.
Conclusion
The use of CPAP in the postoperative period of sleeve gastrec-
tomy in morbidly obese patients is effective in improving
oxygenation, spirometric values, reducing atelectasis and
decreasing postoperative pulmonary complications.Conflict of interest
There is no conflict of interest.
References
[1] R.L. Jones, M.M. Nzekwu, The effects of body mass index on
lung volumes, Chest 130 (2006) 827–833.
[2] W.C. Frey, J. Pilcher, Obstructive sleep-related breathing
disorders in patients evaluated for bariatric surgery, Obes.
Surg. 13 (2003) 676–683.
[3] T.N. Weingarten, M.L. Kendrick, J.M. Swain, L.M. Liedl, C.P.
Johnson, D.R. Schroeder, et al, Effects of CPAP on gastric
pouch pressure after bariatric surgery, Obes. Surg. 21 (2011)
1900–1905.
[4] C.T. Ebeo, P.N. Benotti, R.P. Byrd, Z. Elmaghraby, J. Lui, The
effect of bi-level positive airway pressure on postoperative
pulmonary function following gastric surgery for obesity,
Respir. Med. 96 (2002) 672–676.
[5] P.J. Neligan, G. Malhotra, M. Fraser, N. Williams, E.P.
Greenblatt, M. Cereda, Noninvasive ventilation immediately
after extubation improves lung function in morbidly obese
patients with obstructive sleep apnea undergoing laparoscopic
bariatric surgery, Anesth. Analg. 110 (1360–6) (2010) 5.
[6] J.A. Aldret, The post anesthetic recovery score revisited, J. Clin.
Anesth. 7 (1995) 89–91.
[7] J. Faintuch, S.A. Souza, A.C. Valezi, A.F. Sant’Anna, J.J. Gama-
Rodrigues, Pulmonary function and aerobic capacity in
asymptomatic bariatric candidates with very severe morbid
obesity,Rev.Hosp.Clin. Fac.Med. S. Paulo 59 (4) (2004) 181–186.
[8] A. Eichenberger, S. Proietti, S. Wicky, P. Frascarolo, M. Suter,
D.R. Spahn, et al, Morbid obesity and postoperative pulmonary
atelectasis: an underestimated problem, Anesth. Analg. 95
(2002) 1788–1792.
[9] C.T. Ebeo, P.N. Benotti, R.P. Byrd Jr., Z. Elmaghraby, J. Lui,
The effect of bi-level positive airway pressure on postoperative
pulmonary function following gastric surgery for obesity,
Respir. Med. 96 (9) (2002) 672–676.
[10] J.L. Joris, T.M. Sottiaux, J.D. Chiche, C.J. Desaive, M.L.
Lamy, Effect of bi-level positive airway pressure (BiPAP) nasal
ventilation on the postoperative pulmonary restrictive syndrome
in obese patients undergoing gastroplasty, Chest 111 (3) (1997)
665–670.
[11] S. Huerta, S. DeShields, R. Shpiner, Z. Li, C. Liu, M. Sawicki,
et al, Safety and efficacy of postoperative continuous positive
airway pressure to prevent pulmonary complications after Roux-
en-Y gastric bypass, J. Gastrointest. Surg. 6 (3) (2002) 354–358.
[12] V. Chalhoub, A. Yazigi, G. Sleilaty, F. Haddad, R. Noun, S.
Madi-Jebara, et al, Effect of vital capacity manoeuvres on
arterial oxygenation in morbidly obese patients undergoing open
bariatric surgery, Eur. J. Anaesthesiol. 24 (3) (2007) 283–288.
[13] L. Edmark, K. Kostova-Aherdan, M. Enlund, G. Hedenstierna,
Optimal oxygen concentration during induction of general
anesthesia, Anesthesiology 98 (2003) 28–33.
706 A.A. Hewidy et al.[14] A. Herriger, P. Frascarolo, D.R. Spahn, L. Magnusson, The
effect of positive airway pressure during pre-oxygenation and
induction of anaesthesia upon duration of non-hypoxic apnoea,
Anaesthesia 59 (2004) 243–247.
[15] S.P. Keenan, C. Powers, D.G. McCormack, G. Block,
Noninvasive positive-pressure ventilation for postextubation
respiratory distress: a randomized controlled trial, JAMA 287
(2002) 3238–3244.
[16] S. Ahmad, A. Nagle, R.J. McCarthy, P.C. Fitzgerald, J.T.
Sullivan, J. Prystowsky, Postoperative hypoxemia in morbidly
obese patients with and without obstructive sleep apneaundergoing laparoscopic bariatric surgery, Anesth. Analg. 107
(2008) 138–143.
[17] V. Squadrone, M. Coha, E. Cerutti, M.M. Schellino, P. Biolino,
P. Occella, et al, Continuous positive airway pressure for
treatment of postoperative hypoxemia: a randomized
controlled trial, JAMA 293 (2005) 589–595.
[18] T.N. Weingarten, M.L. Kendrick, J.M. Swain, L.M. Liedl, C.P.
Johnson, D.R. Schroeder, et al, Effects of CPAP on gastric
pouch pressure after bariatric surgery, Obes. Surg. 21 (2011)
1900–1905.
